HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Lomefloxacin

HCID 3948
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
98079-51-7
Standard SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21
InChIKey
ZEKZLJVOYLTDKK-UHFFFAOYSA-N
Molecular formula
C17H19F2N3O3
Average molar mass
351.35 g/mol
Monoisotopic mass
351.1394478

Overview

Lomefloxacin is a fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. It has a role as an antitubercular agent, an antimicrobial agent and a photosensitizing agent. It is a quinolone, a quinolinemonocarboxylic acid, a N-arylpiperazine, a quinolone antibiotic and a fluoroquinolone antibiotic.

Names & identifiers

Preferred name
Lomefloxacin
IUPAC
1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
English name
Lomefloxacin
Molecular formula
C17H19F2N3O3
Molecular weight
351.35

Names & synonyms

lomefloxacin98079-51-7LomefloxacineLomefloxacinoLomefloxacinumLFLX1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidSC-47111AL6BR2WJD8V1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidDTXSID4040680
Show more names
dm-10ClfimonoSC 47111ALomel9actLEMOFLOXACIN
CHEBI:116278(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidLogifloxOkacinSC-4711lomefloxacinalomenfloxacinRefChem:153984

Database identifiers

CAS
98079-51-7
PubChem CID
3948
DTXSID
DTXSID4040680

Properties

Computed structural properties

XLogP
-0.8
Topological polar surface area
72.9 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
8
Rotatable bonds
3
Heavy atoms
25
Formal charge
0
Complexity
585

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Antibiotics

LogP2.8
Solubility1.06e-01 g/L
Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones
Melting Point · 2 items

239-240.5 °C

239 - 240.5 °C

Physical DescriptionSolid
Dissociation Constants5.742
Collision Cross Section · 2 items

191.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

191.04 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Regulatory InformationREACH registered substance: 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecaboylic acid (EC: 619-317-6)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

lomefloxacin

DILI Negative

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6 items

Lomefloxacin

9.3

39.4

The recommended daily dose of lomefloxacin hydrochloride is 400 mg.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 400 mg/day, Lowest Therapeutic Dose (LTD): 5.0 mg/kg-day, and Screening Dose: 0.002 mg/kg-day.

11-May-06

Safety data

Chemistry & industry

Pharmacology

ATC Code · 4 items

S - Sensory organs

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QS - Sensory organs

Protein Binding10%
Pharmacodynamics · 1 item

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as <i>E.coli</i> and <i>Neisseria gonorrhoea</i> as well as gram-positive bacteria including <i>S. pneumoniae</i> and <i>Staphylococcus aureus</i>. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Mechanism of Action · 1 item

Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.

Biological Half-Life8 hours
Metabolism/MetabolitesMinimally metabolized although 5 metabolites have been identified in human urine. 65% appears as the parent drug in urine and 9% as the glucuronide metabolite.
MeSH Pharmacological Classification

Related reactions

4 records
New reaction record
HRID 370714 reaction equation
HRID 370714As product
HRID 370715 reaction equation
HRID 370715As reactant
HRID 370716 reaction equation
HRID 370716As product
HRID 940195 reaction equation
HRID 940195As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL561
ChEBI
CHEBI:116278
UNII
L6BR2WJD8V
EC Number
619-317-6
Nikkaji
J135.046C
Melting point
239 · 239-240 C
Boiling point
542.7 · 542.7±50.0 °C(Predicted)
Density
1.342 · 1.342±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility
DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
form
Solid
pka
-0.25 · -0.25±0.20(Predicted)
color
Pale Yellow to Light Yellow
CAS DataBase Reference
98079 · 98079-51-7(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
6 BR2WJD8V · L6BR2WJD8V
ATC code
1 MA07,S01AE04 · J01MA07,S01AE04
EPA Substance Registry System
3 · 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo- (98079-51-7)
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H312-H332
Precautionary statements
280 · P280
Hazard Codes
Xn,Xi
Risk Statements
22 · 22-36/37/38
Safety Statements
26 · 26-36
WGK Germany
3 · 3
RTECS
1997500 · VB1997500
HS Code
29419000 · 29419000
Toxicity
50 in · LD50 in mice (mg/kg): 245.6 i.v.; >4000 orally (Itoh)
REACH Registrations
Active
wgk
3
rtecs
VB1997500
hs_code
29419000
Toxicity
LD50 in mice (mg/kg): 245.6 i.v.; >4000 orally (Itoh)
risk_code
22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
26-36
Hazard statements
H302-H312-H332
REACH Registrations
Active
Precautionary statements
P280
· 2 items

Substances that inhibit the growth or reproduction of BACTERIA.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and Excretion · 3 items

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

The urinary excretion of lomefloxacin was virtually complete within 72 hours after cessation of dosing, with approximately 65% of the dose being recovered as parent drug and 9% as its glucuronide metabolite.

271 mL/min/1.73 m2 [creatinine clearance of 110 mL/min/1.73 m2]

Cellular LocationsCytoplasm
Applications · 3 items

DescriptionLomefloxacin is a kind of fluoroquinolone antibiotics used for the treatment of bacterial infections such as bronchitis and urinary tract infection. It can also used to prevent the urinary tract infections prior surgery. It has bactericidal effect against a wide range of gram-negative and gram-positive organisms. It takes effect through interfering with the normal function of the bacteria enzyme DNA gyrase and topoisomerase IV, further inhibiting the transcription and replication of bacterial DNA. This effect results in strand breakage of bacterial chromosome, supercoiling and resealing, further causing bacteria death.

DescriptionLomefloxacin is a once-daily, third-generation quinolone antibiotic useful in the treatment of bacterial infections. The new fluorinated quinolone does not interfere with the metabolism of theophylline; it is efficacious against pathogens resistant to cephalosporins, penicillins and aminoglycosides.

UsesAnti bacterial.

Upstream & downstream products

Upstream raw materials

Ethanol2,3,4-Trifluorobenzenamine2-Ethoxy-malonic acid diethyl esterAcetic anhydrideN,N-DimethylformamideAcetoneDiethyl ethoxymethylenemalonate4-Fluorobenzoic acidChloroethaneTriethylamine2-Methylpiperazine1,2-DiphenylethaneLomefloxacin hydrochloridetetrafluorobenzene1,2,3-Trifluoro-4-nitrobenzeneHydrochloric acidBromoethanePyridineThionyl chloride1-Ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-2-quinolinecarboxylic acidSodium bicarbonate

Additional notes

DefinitionChEBI: A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.